Yiting Wang Selected Research

RGERPPR peptide

1/2018

Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yiting Wang Research Topics

Disease

35	Neoplasms (Cancer) 09/2022 - 11/2007
12	Type 2 Diabetes Mellitus (MODY) 10/2021 - 12/2016
10	Inflammation (Inflammations) 06/2022 - 01/2019
10	Chronic Kidney Failure (Chronic Renal Failure) 12/2021 - 01/2018
9	Diabetic Nephropathies (Diabetic Nephropathy) 10/2021 - 01/2018
8	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2018
7	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 10/2014
7	Fibrosis (Cirrhosis) 01/2022 - 01/2018
7	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2020 - 12/2009
6	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2007
6	Proteinuria 04/2020 - 07/2018
5	Prostatic Neoplasms (Prostate Cancer) 02/2017 - 11/2004
4	Chronic Renal Insufficiency 08/2019 - 07/2014
3	Infections 12/2022 - 08/2021
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2015
3	Carcinogenesis 01/2021 - 04/2020
3	Colonic Neoplasms (Colon Cancer) 04/2020 - 11/2015
3	Atrophy 11/2019 - 01/2019
3	Hypertension (High Blood Pressure) 08/2019 - 01/2019
3	Glioma (Gliomas) 01/2019 - 05/2018
2	Endometriosis 06/2022 - 01/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2022 - 06/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2020
2	Crohn Disease (Crohn's Disease) 01/2022 - 03/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2017
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 10/2014
2	Disease Progression 03/2021 - 07/2018
2	Plague (Bubonic Plague) 01/2021 - 11/2016
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 10/2007
2	Renal Insufficiency (Renal Failure) 02/2019 - 07/2018
2	Atrial Fibrillation 01/2019 - 01/2011
2	Carcinoma (Carcinomatosis) 01/2018 - 02/2017
2	Bacillary Dysentery (Shigellosis) 04/2014 - 02/2010
1	Phenylketonurias (Phenylketonuria) 09/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022
1	Adenomyosis 06/2022
1	Liver Neoplasms (Liver Cancer) 05/2022
1	Spontaneous Abortion (Miscarriage) 01/2022

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 03/2022 - 01/2011
11	Proteins (Proteins, Gene)FDA Link 06/2022 - 02/2017
7	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2022 - 10/2014
6	Biomarkers (Surrogate Marker)IBA 06/2022 - 08/2017
6	Paclitaxel (Taxol)FDA LinkGeneric 04/2021 - 01/2011
6	PolymersIBA 04/2021 - 01/2011
4	Biological ProductsIBA 03/2021 - 01/2018
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 05/2018
4	Immunoglobulin G (IgG)IBA 07/2020 - 01/2019
4	CreatinineIBA 01/2019 - 01/2018
3	Chimeric Antigen ReceptorsIBA 09/2022 - 01/2017
3	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2020
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
3	Indicators and Reagents (Reagents)IBA 12/2021 - 07/2018
3	Circular RNAIBA 01/2021 - 01/2019
3	Therapeutic UsesIBA 01/2020 - 12/2009
3	Peptides (Polypeptides)IBA 01/2020 - 11/2017
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2019 - 01/2019
3	poly(gamma-glutamylglutamine)paclitaxelIBA 11/2017 - 01/2011
2	AntigensIBA 09/2022 - 05/2021
2	Amino Acids FDA Link 09/2022 - 08/2021
2	CytokinesIBA 09/2022 - 01/2018
2	IronIBA 05/2022 - 06/2021
2	HMGB1 Protein (HMG1)IBA 01/2022 - 01/2020
2	Lipid NanoparticlesIBA 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 11/2020
2	VaccinesIBA 03/2021 - 02/2010
2	Cadherins (E-Cadherin)IBA 01/2021 - 01/2018
2	Monoclonal AntibodiesIBA 11/2020 - 08/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 04/2008
2	CholesterolIBA 04/2020 - 11/2007
2	Fibrinogen (Factor I)FDA Link 11/2019 - 07/2018
2	AcidsIBA 08/2019 - 01/2017
2	Complement C3 (C3 Complement)IBA 08/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 06/2019 - 12/2016
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 06/2016
2	Nanoparticle Drug Delivery SystemIBA 01/2018 - 01/2015
2	Gadolinium DTPA (Magnevist)FDA Link 01/2018 - 01/2017
2	poly(gamma- glutamylcarbocysteine)paclitaxelIBA 12/2017 - 10/2017
2	Cytochrome P-450 CYP3AIBA 01/2017 - 11/2004
2	Diphosphonates (Bisphosphonates)IBA 01/2011 - 01/2011
2	Erythropoietin FDA Link 07/2010 - 12/2009
2	Retinaldehyde (Retinal)IBA 07/2010 - 12/2009
2	Estrogens (Estrogen)FDA Link 10/2007 - 09/2006
1	MacrolidesIBA 12/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2022
1	Heavy Chain Fusion Regulatory Protein 1IBA 05/2022
1	4-phenylbutyric acid (Buphenyl)FDA Link 03/2022
1	ursodoxicoltaurineIBA 03/2022
1	SeleniumIBA 03/2022
1	Ustekinumab (CNTO 1275)FDA Link 01/2022
1	Antisense RNA (Anti-Sense RNA)IBA 01/2022

Therapy/Procedure

12	Therapeutics 10/2021 - 01/2011
2	General Anesthesia 01/2022 - 01/2021
2	Radiotherapy 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 04/2021 - 06/2016
2	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2019 - 01/2019
2	Precision Medicine 01/2018 - 01/2017
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 10/2007 - 09/2006
1	Diet Therapy (Therapy, Diet) 06/2022
1	Induced Abortion (Induced Abortions) 01/2022